[1]刘亚东,冯莉莉,王海晶,等.冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析[J].现代检验医学杂志,2018,33(06):83-87.[doi:10.3969/j.issn.1671-7414.2018.06.022]
　LIU Ya-dong,FENG Li-li,WANG Hai-jing,et al.Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2018,33(06):83-87.[doi:10.3969/j.issn.1671-7414.2018.06.022]
点击复制

冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
83-87
栏目:
论著
出版日期:
2018-12-24

文章信息/Info

Title:
Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease
文章编号:
1671-7414(2018)06-083-05
作者:
刘亚东1; 冯莉莉1; 王海晶1; 王丽萍1; 李永莉2
1.延安大学附属医院心脑血管病区检验科,陕西延安 716000; 2.安康市汉滨区第二医院检验科,陕西安康 725021
Author(s):
LIU Ya-dong1; FENG Li-li1; WANG Hai-jing1; WANG Li-ping1; LI Yong-li2
Department of Clinical Laboratory,Department of Cardiovascularand Cerebrovascular Disease, Affiliated Hospital of Yan'an University,Shaanxi Yan'an 716000,China; 2.Department of Clinical Laboratory,Ankang Hanbin District Second Hospital,Shaanxi Ankang 725021,China
关键词:
冠心病;  脂蛋白相关磷脂酶A2;  同型半胱氨酸;  冠状动脉粥样硬化;  Gensini积分
分类号:
R541.4; R446.112
DOI:
10.3969/j.issn.1671-7414.2018.06.022
文献标志码:
A
摘要:
目的 探讨血清脂蛋白相关磷脂酶A2(Lp-PLA2)和同型半胱氨酸(HCY)水平检测与冠心病(CHP)患者冠状动脉病变程度的关系。方法 选取2017年1月～2018年5月延安大学附属医院经冠状动脉造影确诊的冠心病患者266例为实验组,其中男性161例,平均年龄57.3±8.5岁,女性105例,平均年龄61.1±11.6岁,选取同期该院冠状动脉造影阴性的体检者180例为对照组,其中男性97例,平均年龄54.6±10.5岁,女性83例,平均年龄47.5±6.3岁,记录两组性别、年龄、糖尿病史、卒中病史、心肌梗死病史、吸烟史和饮酒史,使用贝克曼AU2700全自动生化分析仪测定两组HCY,Lp-PLA2,空腹血糖(FBG)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和脂蛋白(a)[Lp(a)]水平,分析两组各项指标的差异。秩和检验比较Gensini积分组 [低积分组(Gensini积分<14分,n=128),中积分组(Gensini积分14～28分,n=83),高积分组(Gensini积分>28分,n=55)共3组] Lp(a),HCY水平之间的差异,秩和检验比较冠状动脉不同支数病变组 [1支病变组(n=87)、2支病变组(n=91)、3支及3支以上病变组(n=88)共3组] Lp(a),HCY水平之间的差异。采用Pearson法分析Gensini积分与Lp-PLA2,HCY水平之间的相关性及Lp-PLA2与HCY水平之间的相关性。结果 实验组与对照组吸烟史、饮酒史及HCY,Lp-PLA2,Lp(a)水平为:59.77% vs 38.9%,86.84% vs 76.67%,53.7±21.8 μmol/L vs 6.5±4.1 μmol/L,366.1±114.3 μg/L vs 115.4±48.4 μg/L,569±283 mg/L vs 107±75.8 mg/L,差异均有统计学意义(t或χ2=7.78～18.75,均P<0.05)。Gensini低积分组、中积分组、高积分组HCY和Lp-PLA2水平为:39.6±20.2 μmol/L,50.7±26.4 μmol /L,68.5±31.8 μmol/L和245.4±88.3 μg/L,326.1±104.3 μg/L,459.4±113.5 μg/L,差异均有统计学意义(Z=5.81,15.25,均P<0.05)。冠状动脉1支病变组、2支病变组、3支及3支以上病变组HCY和Lp-PLA2水平为:48.6±27.2 μmol/L,47.8±23 μmol /L,74.1±38.6 μmol/L和201.4±73.5 μg/L,344.1±134.2 μg/L,530.6±255.3 μg/L,差异均有统计学意义(Z=5.63,17.91,均P<0.05),随Gensini积分的增加和冠状动脉病变支数的增多,HCY和Lp-PLA2水平升高,差异有统计学意义(t=5.43～16.57,均P<0.05),相关性分析显示Gensini积分与Lp-PLA2,HCY水平呈正相关(r=0.454,0.991,均P<0.05)。Lp-PLA2与HCY水平呈正相关(r=0.336,P<0.05)。结论 冠心病患者Lp-PLA2,HCY水平与冠状动脉病变程度呈正相关。
Abstract:
Objective to explore the correlation between serum lipoprotein-related phospholipase A2(Lp-PLA2)and homocysteine(HCY)levels and the degree of coronary artery disease in patients with coronary heart disease.Methods Selection methods between January 2017 and May 2018,delay of establishing affiliated hospital after coronary angiography diagnosis of 266 patients with coronary heart disease(CHD)as the experimental group,161 cases of men,average age(57.3±8.5 years),105 cases of female,average age(61.1±11.6 years),select the same negative coronary angiography inour medical 180 cases as control group,97 cases of men,average age(54.6±10.5 years),83 cases of female,average age(47.5±6.3 years),History recordsof two groups of gender,age,diabetes mellitus,history of stroke,myocardialinfarction,history,history of smoking,drinking alcohol,using beckman AU2700automatic biochemical analyzer determination of two groups of HCY,Lp-PLA2,fasting blood glucose(FBG),three acyl glycerin(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),lipoprotein(a)[Lp(a)]level,analysis the difference of each indexin both groups.Rank and inspection comparison Gensini score [low score group(Gensini score <14 points,n=128),the integral group(Gensini score 14 ～28points,n=83),the high score group(Gensini score >28 points,n=55)atotal of three groups]Lp(a),the difference between HCY levels,rank and inspection comparison of coronary artery counts lesion group [1 lesion group(n=87),two lesion group(n=91),more than three and three lesion group(n=88),a total of 3] Lp(a),the difference between HCY levels.Pearson method was used to analyze the correlation between Gensini integral and Lp-PLA2 and HCYlevels and the correlation between Lp-PLA2 and HCY levels.ResultsThe smoking and drinking history of the experimental group and the control group as well as the levels of HCY,Lp-PLA2 and Lp(a)were:59.77% vs 38.9%,86.84% vs 76.67%,53.7±21.8 μmol/L vs 6.5±4.1 μmol/L,366.1±114.3 μg/L vs 115.4±48.4 μg/L and 569±283 mg/L vs 107±75.8 mg/L,thedifference was statistically significant(t or χ2=7.78～18.75, allP<0.05).The levels of HCY and Lp-PLA2 in the low-integral,medium-integral and high-integral groups of Gensini were:39.6±20.2 μmol/L,50.7±26.4 μmol /L,68.5±31.8 μmol /L and 245.4±88.3 μg/L,326.1±104.3 μg/L,459.4±113.5 μg/L with statistically significant differences(Z=5.81,15.25, all P<0.05).HCY and Lp-PLA2 levels were:48.6±27.2 μmol/L,47.8±23 μmol /L,74.1±38.6 μmol/L and 201.4±73.5 μg/L,344.1±134.2 μg/L,530.6±255.3 μg/L,with statistically significant differences(Z=5.63,17.91,all P<0.05).HCY and Lp-PLA2 levels increased with the increase of Gensini integral and coronary artery disease count(t=5.43～16.57,mean P<0.05).Correlation analysis showed that Gensini integral was positively correlated with Lp-PLA2 and HCY levels(r=0.454,0.991,mean P<0.05).Lp-PLA2 was positively correlated with HCY(r=0.336,P<0.05).Conclusion The levels of Lp-PLA2 and HCY in patients with coronary heart disease were positively correlated with the degree of coronaryartery disease.

参考文献/References:

[1] 中国心血管病报告编写组.中国心血管病报告2013概要[J].中国循环杂志,2014,29(7):487-491.
China Cardiovascular Disease Report Writing Group.Chinese cardiovascular disease report 2013 summary[J].Chinese Circulation Journal,2014,29(7):487-491.
[2] Libby P.Inflammation in atherosclerosis[J].Review Article,2002,420(8):868-874.
[3] Gupta S,Gudapati R,Gaurav K,et al.Emerging risk factors for cardiovascular diseases:Indian context[J].Indian J Endocrinol Metab,2013,17(5):806-814.
[4] Libby P.Inflammtion and atherosclerosis[J].Circulation,2002,5(9):1135-1143.
[5] 马 旭,袁 慧,刘荣凤.冠心病患者血清胆固醇对脂蛋白相关磷脂酶A2活性水平的影响[J].中华检验医学杂志,2013,36(2):185-187.
Ma X,Yuan H,Liu RF.Effects of serum cholesterol on lipoprotein-associated phospholipase A2 activity in patients with coronary heart disease [J].Chinese Journal of Laboratory Medicine,2013,36(2):185-187.
[6] Wu W,Guan Y,Xu K,et al.Plasma homocysteine levels predict the risk ofacute cerebral infarction in patients with carotid artery lesions[J].Mol Neurobiol,2016,53(4):2510-2517.
[7] Yang F,Tan HM,Wang H.Hyperhomocysteinemia and atherosclerosis[J].Acta Physiologica Sinica,2005,57(2):103-114.
[8] Han XB, Zhang HP, Cao CJ,et al.Aberrant DNA methylation of the PDGF gene in homocysteine mediated VSMC proliferation and its underlying mechanism[J].Mol Med Rep,2014,10(2):947-954.
[9] 张志世,王凌燕.同型半胱氨酸与冠心病[J].中国循环杂志,2016,31(4):405-407.
Zhang ZS,Wang LY.Homocysteine and coronary he-art disease[J].Chinese Circulation Journal,2016,31(4):405-407.
[10] Gensini GG.A more meaningful scoring system for determining theseverity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
[11] 谷明林,姚孝明,王志华,等.稳定性冠心病患者血清超敏心肌肌钙蛋白T水平与冠状动脉病变程度的相关性研究[J].中国循环杂志,2016,31(6):559-563.
Gu ML,Yao XM,Wang ZH,et al.Relationship between serum levels of high sensitivity cardiac troponin T and the severity of coronary lesions in patients with stable coronary artery disease[J].Chinese Circulation Journal,2016,31(6):559-563.
[12] Hassan M.STABILITY and SOLID-TIMI 52:Lipoprotein associated phospholipase A2(Lp-PLA2)as a biomarker or risk factor for cardiovascular diseases[J].Glob Cardiol Sci Pract,2015,2015(1):6.
[13] 徐瑞霞,李 莎,郭远林,等.高密度脂蛋白颗粒与稳定型冠心病的相关性研究[J].中国循环杂志,2013,28(5):352-355.
Xu RX,Li S,Guo YL,et al.Correlation study between the concentrations of high-density lipoprotein sub-fractions and coronary artery disease[J].Chinese Circulation Journal,2013,28(5):352-355.
[14] 孟心国,陈 魁.血浆脂蛋白相关磷脂酶A2水平与冠心病冠脉血管病变数量的关系分析[J].医学与哲学,2016,37(6B):37-40.
Meng XG,Chen K.Correlation analysis of the levels of plasma lipoprotein-associated phospholipase A2 with coronary artery lesions range[J].Medicineand Philosophy,2016,37(6B):37-40.
[15] Burke JE,Dennis EA.Phospholipase A2 biochemistry[J].Cardiovasc Drugs Ther,2009,23(1):49-59.
[16] 唐 兰,邹桂和,刘 彬,等.冠心病新型炎症标志物—脂蛋白相关磷脂酶A[J].当代医学,2018,24(8):183-184.
Tang L,Zou GH,Liu B,et al.A new inflammatory marker of coronary heartdisease -lipoprotein-associated phospholipase A2[J].Contemporary Medicine,2008,24(8):183-184.
[17] 宋兆炎,李京秀,郭龙哲,等.同型半胱氨酸与冠状动脉粥样硬化性心脏病相关性研究进展[J].新乡医学院学报,2018,35(4):347-351.
Song ZY,Li JX,Guo LZ,et al.Research progress of correlation between homocysteine and coronary atherosclerotic heart disease[J].Journal of XinxiangMedical University,2018,35(4):347-351.
[18] 黄 晖,严 宁,王义勇,等.冠心病患者血浆同型半胱氨酸水平与冠状动脉病变SYNTAX积分的相关性研究[J].中国全科医学,2017,20(10):1208-1224.
Huang H,Yan N,Wang YY,et al.Correlation between the levels of plasma Hcy and the SYNTAX score of coronary artery disease of patients with coronary heart disease[J].Chinese General Practice,2017,20(10):1208-1224.
[19] 刘夏炎,余安运,于佩方,等.RDW,HCY和LP(a)在高血压及冠心病中的临床应用[J].现代检验医学杂志,2017,32(4):80-82,86.
Liu XY,Yu AY,Yu PF,et al.Clinical application of RDW,HCY and LP(a)inhight blood pressure and combined coronary heart disease[J].Journal of Modern Laboratory Medicine,2017,32(4):80-82,86.

相似文献/References:

[1]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
　HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(06):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[2]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
　HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2 and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[3]赵佳a,姚创利a,左林,等.冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J].现代检验医学杂志,2015,30(05):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
　ZHAO Jiaa,YAO Chuang-lia,ZUO Lin,et al.Effects of Homocysteine on Blood Lipid and Manganese Superoxide Dismutase in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
[4]李 垚,杨 平.早发冠心病触珠蛋白水平及其在免疫调节中的作用研究[J].现代检验医学杂志,2015,30(01):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
　LI Yao,YANG Ping.Role of Haptoglobin in the Immunomodulatory in Patients with Premature Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
[5]高宏娥,李荫桂,黄海云,等.缺血性脑卒中患者血浆脂蛋白相关磷脂酶A2测定的临床意义[J].现代检验医学杂志,2015,30(02):58.[doi:10.3969/j.issn.1671-7414.2015.02.018]
　GAO Hong-e,LI Yin-gui,HUANG Hai-yun,et al.Clinical Significance of Plasma Lipoprotein-Associated Phospholipase A2 Detecting in Patients with Ischemic Cerebral Stroke[J].Journal of Modern Laboratory Medicine,2015,30(06):58.[doi:10.3969/j.issn.1671-7414.2015.02.018]
[6]张 蕾,陈 捷,陈玉婷.冠心病并发恶性肿瘤患者Ghrelin/obestatin比值变化及意义[J].现代检验医学杂志,2016,31(04):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
　ZHANG Lei,CHEN Jie,CHEN Yu-ting.Change and Significance of Ghrelin/Obestatin in Patients with Coronary Heart Disease Complicated with Malignant Tumor[J].Journal of Modern Laboratory Medicine,2016,31(06):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
[7]赵 佳,左 林,姚创利,等.冠心病患者血清同型半胱氨酸水平与氧化应激的关系研究[J].现代检验医学杂志,2016,31(05):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
　ZHAO Jia,ZUO Lin,YAO Chuang-li,et al.Study on the Relationship between Serum Homocysteine Levels and Oxidative Stress in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(06):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
[8]姚创利,黎 阳,鲁旭娟,等.超氧化物歧化酶及其同工酶和超敏C-反应蛋白与冠心病的关系[J].现代检验医学杂志,2016,31(05):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
　YAO Chuang-li,LI Yang,LU Xu-juan,et al.Relationship of Superoxide Dismutase Isoenzyme and High Sensitive C-Reactive Protein with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(06):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
[9]黄生金,郑利平,陆俊佳,等.广西地区壮族和汉族冠心病患者胱抑素C水平及其基因多态性的比较研究[J].现代检验医学杂志,2017,32(03):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
　HUANG Sheng-jin,ZHENG Li-ping,LU Jun-jia,et al.Comparative Study of Cystatin C and Its Gene Polymorphism of Pati ents with Coronary Heart Disease between Zhuang and Han in Guangxi Region[J].Journal of Modern Laboratory Medicine,2017,32(06):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
[10]刘 玥,刘西玲,张 欣,等.Lp-PLA2,Hcy,HbA1c,LDL-C水平与脑微出血相关性研究[J].现代检验医学杂志,2017,32(06):35.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　LIU Yue,LIU Xi-ling,ZHANG Xin,et al.Study on the Relationship between Lipoprotein-Related Phospholipase A2,Homocysteine,Beta-N-1-Deoxy Fructosyl Component of Hemoglobin and Cerebral Microbleeds[J].Journal of Modern Laboratory Medicine,2017,32(06):35.[doi:10.3969/j.issn.1671-7414.2017.06.001]

备注/Memo

备注/Memo:
作者简介:刘亚东(1988-),男,大学本科,主管检验师,专业:生化检验,E-mail:769505260@qq.com。
通讯作者:李永莉(1971-),女,E-mail:407629149@qq.com。
更新日期/Last Update: 2018-11-30